article · BMC Cancer

Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications

Emad Shash
Salha Boujassoum
Ahmed Aboutaleb
Eman Samy
Cagatay Taskiran
Jamila Riromar
Farah Sadek
Mehemet Ali Vardar
Waleed Bahaj

2026Open accessCairo University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

PARP inhibition in cancer therapy
BRCA gene mutations in cancer
DNA Repair Mechanisms

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12885-025-15537-3

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.